Related Experiment Video
Updated: Feb 16, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
18F-Fluorodeoxyglucose PET/CT and dynamic contrast-enhanced MRI as imaging biomarkers in malignant pleural
David O Hall1,2, Clare E Hooper3,4,5, Julie Searle1,6
1Cobalt Health, Cobalt Imaging Centre, Cheltenham.
Purpose:
The purpose of this study was to compare the use of fluorine-18-fluorodeoxyglucose (F-FDG) PET with computed tomography (CT) and dynamic contrast-enhanced (DCE) MRI to predict prognosis and monitor treatment in malignant pleural mesothelioma.
Patients And Methods:
F-FDG PET/CT and DCE-MRI studies carried out as part of the South West Area Mesothelioma Pemetrexed trial were used. F-FDG PET/CT and DCE-MRI studies were carried out before treatment, and after two cycles of chemotherapy, on patients treated with pemetrexed and cisplatin. A total of 73 patients were recruited, of whom 65 had PET/CT and DCE-MRI scans. Baseline measurements from F-FDG PET/CT (maximum standardized uptake value, metabolic tumour volume and total lesion glycolysis) and DCE-MRI (integrated area under the first 90s of the curve and washout slope) were compared with overall survival (OS) using Kaplan-Meier and Cox regression analyses, and changes in imaging measurements were compared with disease progression.
Results:
PET/CT and DCE-MRI measurements were not correlated with each other. Maximum standardized uptake value, metabolic tumour volume and total lesion glycolysis were significantly related to OS with Cox regression analysis and Kaplan-Meir analysis, and DCE-MRI washout curve shape was significantly related to OS. DCE-MRI curve shape can be combined with F-FDG PET/CT to give additional prognostic information. Changes in measurements were not related to progression-free survival.
Conclusions:
F-FDG PET/CT and DCE-MRI give prognostic information in malignant pleural mesothelioma. Neither PET/CT nor DCE-MRI is useful for monitoring disease progression.
Insights
Fluorine-18-fluorodeoxyglucose (F-FDG) PET/CT and dynamic contrast-enhanced (DCE) MRI both offer prognostic information for malignant pleural mesothelioma. However, neither imaging technique is effective for monitoring disease progression during treatment.
Area of Science:
- Oncology
- Radiology
- Nuclear Medicine
Background:
- Malignant pleural mesothelioma is an aggressive cancer with limited treatment options.
- Accurate prognostic and monitoring tools are crucial for optimizing patient management.
Purpose of the Study:
- To compare fluorine-18-fluorodeoxyglucose (F-FDG) PET/CT and dynamic contrast-enhanced (DCE) MRI for predicting prognosis and monitoring treatment response in malignant pleural mesothelioma.
- To evaluate the utility of specific imaging metrics from both modalities in relation to patient survival and disease progression.
Main Methods:
- Utilized data from the South West Area Mesothelioma Pemetrexed trial, including F-FDG PET/CT and DCE-MRI scans before and after chemotherapy.
- Analyzed baseline imaging measurements (e.g., SUVmax, MTV, TLG for PET/CT; curve shape, washout for DCE-MRI) against overall survival (OS) using Kaplan-Meier and Cox regression.
- Assessed changes in imaging measurements for correlation with progression-free survival.
Main Results:
- F-FDG PET/CT and DCE-MRI measurements were not significantly correlated with each other.
- Key F-FDG PET/CT metrics (SUVmax, MTV, TLG) and DCE-MRI washout curve shape were significantly associated with OS.
- Combining DCE-MRI curve shape with F-FDG PET/CT provided additional prognostic value.
- Changes in imaging measurements did not correlate with progression-free survival.
Conclusions:
- Both F-FDG PET/CT and DCE-MRI provide valuable prognostic information in malignant pleural mesothelioma.
- Neither imaging modality is suitable for monitoring disease progression during treatment.
- Further research may explore combined imaging approaches for improved prognostic assessment.
Related Concept Videos
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Imaging Studies for Cardiovascular System V: CT
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Phase Contrast and Differential Interference Contrast Microscopy
In-phase-contrast microscopes, interference between light directly passing through a cell and light refracted by cellular components is used to create high-contrast, high-resolution images without staining. It is the oldest and simplest type of microscope that creates an image by altering the wavelengths of light rays passing through the specimen. Altered wavelength paths are created using an annular stop in the condenser. The annular stop produces a hollow cone of...
Pleural Disorders: Types and Brief Description
![Quantitative [18F]-Naf-PET-MRI Analysis for the Evaluation of Dynamic Bone Turnover in a Patient with Facetogenic Low Back Pain](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58491.jpg&w=3840&q=50)
